Monitoring ligand-mediated internalization of G protein-coupled receptor as a novel pharmacological approach

Life Sciences

Volumn 80, Issue 1, 2006, Pages 17-23

  Fukunaga, Shin'ichi ^a   Setoguchi, Shingo ^a   Hirasawa, Akira ^a   Tsujimoto, Gozoh ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Fluorescence imaging; G protein coupled receptor; Internalization; Orphan receptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADRENALIN; AMOSULALOL; BETA 2 ADRENERGIC RECEPTOR; DESMOPRESSIN; FATTY ACID; G PROTEIN COUPLED RECEPTOR; GREEN FLUORESCENT PROTEIN; ISOPRENALINE; NORADRENALIN; OXYTOCIN; PROCATEROL; PROPRANOLOL; PROTON; SALBUTAMOL; UNCLASSIFIED DRUG; VASOPRESSIN V1 ALPHA RECEPTOR; VASOPRESSIN V1 RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVATION; DRUG INHIBITION; DRUG RECEPTOR BINDING; EMBRYO; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE PROCESSING; IMAGING SYSTEM; INTERNALIZATION; LIGAND BINDING; MONITORING; NONHUMAN; PROTEIN TRANSPORT;

ANIMALS; CELL LINE; GREEN FLUORESCENT PROTEINS; HUMANS; LIGANDS; MICE; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, VASOPRESSIN;

EID: 33751311273     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.08.022     Document Type: Article

References (32)

1. 1b-adrenoceptor with green fluorescent protein. Molecular Endocrinology 12 8 (1998) 1099-1111
2. 2-adrenergic receptor-green fluorescent protein conjugate. Molecular Pharmacology 51 2 (1997) 177-184
3. Benovic J.L., Shorr R.G., Caron M.G., and Lefkowitz R.J. The mammalian beta 2-adrenergic receptor: purification and characterization. Biochemistry 23 20 (1984) 4510-4518
4. Berrada K., Plesnicher C.L., Luo X., and Thibonnier M. Dynamic interaction of human vasopressin/oxytocin receptor subtypes with G protein-coupled receptor kinases and protein kinase C after agonist stimulation. The Journal of Biological Chemistry 275 35 (2000) 27229-27237
5. Bhowmick N., Narayan P., and Puett D. The endothelin subtype A receptor undergoes agonist-and antagonist-mediated internalization in the absence of signaling. Endocrinology 139 7 (1998) 3185-3192
6. 2+in rat medullary collecting tubules. The American Journal of Physiology 265 1 Pt 2 (1993) F35-F45
7. Conway B.R., Minor L.K., Xu J.Z., Gunnet J.W., DeBiasio R., D'Andrea M.R., Rubin R., Giuliano K., DeBiasio L., and Demarest K.T. Quantification of G-protein coupled receptor internatilization using G-protein coupled receptor-green fluorescent protein conjugates with the ArrayScan™ high-content screening system. Journal of Biomolecular Screening 4 2 (1999) 75-86
8. Delhaye M., Taton G., Camus J.C., Chatelain P., Robberecht P., Waelbroeck M., and Christophe J. Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase. Biochemical Pharmacology 32 12 (1983) 1831-1835
9. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacological Reviews 53 1 (2001) 1-24
10. Gudermann T., Schoneberg T., and Schultz G. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annual Review of Neuroscience 20 (1997) 399-427
11. Hilairet S., Belanger C., Bertrand J., Laperriere A., Foord S.M., and Bouvier M. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and beta-arrestin. The Journal of Biological Chemistry 276 45 (2001) 42182-42190
12. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., and Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nature Medicine 11 1 (2005) 90-94
13. 1a vasopressin receptor. European Journal of Biochemistry 213 2 (1993) 711-719
14. Huang Z., Bambino T., Chen Y., Lameh J., and Nissenson R.A. Role of signal transduction in internalization of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein. Endocrinology 140 3 (1999) 1294-1300
15. 2-adrenergic receptors for subtype-selective agonists. Molecular Pharmacology 56 5 (1999) 875-885
16. Jard S., Gaillard R.C., Guillon G., Marie J., Schoenenberg P., Muller A.F., Manning M., and Sawyer W.H. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Molecular Pharmacology 30 2 (1986) 171-177
17. 2-adrenergic receptor. The Journal of Biological Chemistry 273 1 (1998) 322-328
18. 1b vasopressin receptor genes. Japanese Journal of Pharmacology 81 4 (1999) 388-392
19. Laszlo F.A., Laszlo Jr. F., and De Wied D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacological Reviews 43 1 (1991) 73-108
20. Liu M., and Kirchgessner A.L. Agonist-and reflex-evoked internalization of metabotropic glutamate receptor 5 in enteric neurons. The Journal of Neuroscience 20 9 (2000) 3200-3205
21. Milligan G. Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent protein. British Journal of Pharmacology 128 3 (1999) 501-510
22. 1 adenosine receptors in a pituitary-derived cell line. Brain Research 816 1 (1999) 47-57
23. 2 receptor. Experimental Cell Research 244 1 (1998) 327-339
24. 1 receptor antagonist. Neuroscience 27 3 (1988) 749-761
25. Roettger B.F., Ghanekar D., Rao R., Toledo C., Yingling J., Pinon D., and Miller L.J. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Molecular Pharmacology 51 3 (1997) 357-362
26. Schlag B.D., Lou Z., Fennell M., and Dunlop J. Ligand dependency of 5-hydroxytryptamine 2C receptor internalization. The Journal of Pharmacology and Experimental Therapeutics 310 3 (2004) 865-870
27. 2 receptor are essential for cell surface transport in COS.M6 cells. Molecular Pharmacology 54 3 (1998) 525-535
28. Stoschitzky K., Lindner W., and Kiowski W. Stereoselective vascular effects of the (R)-and (S)-enantiomers of propranolol and atenolol. Journal of Cardiovascular Pharmacology 25 2 (1995) 268-272
29. Tarasova N.I., Stauber R.H., Choi J.K., Hudson E.A., Czerwinski G., Miller J.L., Pavlakis G.N., Michejda C.J., and Wank S.A. Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. The Journal of Biological Chemistry 272 23 (1997) 14817-14824
30. Wang J.Q., Kon J., Mogi C., Tobo M., Damirin A., Sato K., Komachi M., Malchinkhuu E., Murata N., Kimura T., Kuwabara A., Wakamatsu K., Koizumi H., Uede T., Tsujimoto G., Kurose H., Sato T., Harada A., Misawa N., Tomura H., and Okajima F. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. The Journal of Biological Chemistry 279 44 (2004) 45626-45633
31. 2A receptors in vitro and in vivo. Annals of the New York Academy of Sciences 861 (1998) 121-127
32. Zhang J., Ferguson S.S., Barak L.S., Bodduluri S.R., Laporte S.A., Law P.Y., and Caron M.G. Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proceedings of the National Academy of Sciences of the United States of America 95 12 (1998) 7157-7162